An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

NCT06427681 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability

Interventions

DRUG: BH006 for injection
DRUG: Fosaprepitant for injection+Palonosetron hydrochloride injection

Sponsor

Zhuhai Beihai Biotech Co., Ltd